The Rutgers Health Surgical Care of End-Stage Lung Disease program provides comprehensive surgical treatment for end-stage lung disease.

Treatment includes slowing disease progress and reducing the severity of symptoms. Our team of physicians and other medical professionals work to improve quality of life, minimize symptoms and complications, and optimize lung function.

The program offers many treatments and services, including:

• Lung volume reduction surgery to remove lung tissue damage and allow growth of the remaining (often more functional) lung
• Pulmonary thromboendarterectomy (an operation to remove clotted blood from pulmonary arteries that supply the lungs with blood)

Physicians who serve our program are on the faculty of Rutgers Robert Wood Johnson Medical School, a part of Rutgers University, one of the top research institutions in America. Our doctors are active in research and teach about all aspects of end-stage lung disease and cardiothoracic surgery. Each brings leading-edge knowledge from the classroom to the exam room.

If you or a loved one is seeking treatment for end-stage lung disease, please make an appointment with the Rutgers Health Surgical Care of End-Stage Lung Disease program today.